Results 41 to 50 of about 1,255 (179)

7-Year Efficacy and Safety of iStent inject Trabecular Micro-Bypass in Combined and Standalone Usage [PDF]

Advances in Therapy
Hengerer FH, Auffarth GU, Conrad-Hengerer I.   +2 more
exaly   +2 more sources

Preventing glaucoma progression using the trabecular micro-bypass implant iStent inject®. A cost-effectiveness analysis

Revista Brasileira de Oftalmologia, 2021
Objective To assess the economic impact of reducing glaucoma progression by using the trabecular micro-bypass implant, iStent inject®, in the Reference Centers for glaucoma treatment within the Brazilian Public Unified Health System (SUS).
Ricardo Augusto Paletta Guedes, Camila Pepe, Leticia Dias, Laura Murta, Daniela Marcelo Gravina, Alfredo Chaoubah   +5 more
doaj   +1 more source

Mispositioned Hydrus Microstents: A Case Series Imaged with NIDEK GS‐1 Gonioscope

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Introduction. The Hydrus microstent has become a common procedure in glaucoma surgery intended to improve outcomes of cataract surgery to lower intraocular pressure. Despite proper placement, this device can subsequently be noted to not be in the proper position. In this case series, we report mispositioned Hydrus microstents in five different patients
Daniel Laroche, Alexander Martin, Aaron Brown, Sohail Sakkari, Chester Ng, Miguel Teus   +5 more
wiley   +1 more source

Minimal-invasiv glaukomkirurgi (MIGS) for individer med glaukom. En metodevurdering [PDF]

, 2021
Executive summary Background: Glaucoma is a substantial public health problem, with a large negative impact on quality of life and the utilization of health care resources.
Bidonde, Julia, Kornør, Hege, Kvist, Beate Charlotte Fagerlund, Lerner, Martin Robert, Lund, Ulrikke Højslev, Nguyen, Lien, Reinar, Liv Merete Brynildsen, Robberstad, Bjarne, Ursin, Lars Øystein   +8 more
core   +6 more sources

Outcomes of Anterior Chamber, Sulcus, and Pars Plana Glaucoma Drainage Device Placement in Glaucoma Patients

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Purpose. To assess outcomes of anterior chamber (AC), sulcus, and pars plana (PP) glaucoma drainage device (GDD) placement in glaucoma patients. Patients and Methods. Retrospective evaluation of glaucoma patients who underwent GDD insertion in the AC, sulcus, or PP at Massachusetts Eye and Ear between November 2016 and May 2021.
Sandy Samuel, Enchi K. Chang, Sanchay Gupta, Marika Chachanidze, Cameron E. Neeson, John B. Miller, Ta Chen Chang, David A. Solá-Del Valle, Alessandro Meduri   +8 more
wiley   +1 more source

Prevalence of zonulopathy in primary angle closure disease

Clinical &Experimental Ophthalmology, Volume 49, Issue 9, Page 1018-1026, December 2021., 2021
Abstract Background To determine the prevalence of zonulopathy in a large cohort of eyes with primary angle closure disease (PACD) that underwent cataract surgery. Methods Retrospective consecutive case series of PACD eyes (including primary angle closure suspect, primary angle closure, and primary angle closure glaucoma) that underwent ...
Ali Salimi, Anthony Fanous, Harrison Watt, Mohamed Abu‐Nada, Anna Wang, Paul Harasymowycz   +5 more
wiley   +1 more source

Prospective unmasked randomized evaluation of the iStent inject (®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma. [PDF]

, 2014
PURPOSE: The purpose of this study was to compare outcomes of subjects with open-angle glaucoma (OAG) not controlled on one medication who underwent either implantation of two iStent inject (®) trabecular micro-bypass devices or received medical therapy ...
Anselm Juenemann, Antonio Fea, Jose Isidro Belda Sanchis, L. Jay Katz, Lilit Voskanyan, Luis Pablo, Lydia Chang, Marek Rekas, null Giamporcaro   +8 more
core   +4 more sources

XEN® Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open‐angle glaucoma: two‐year results

Acta Ophthalmologica, Volume 99, Issue 3, Page e433-e440, May 2021., 2021
Abstract Purpose To evaluate the long‐term efficacy and safety of two minimally invasive glaucoma surgery implants with a subconjunctival drainage approach: the XEN45 Gel Stent® (Xen) implant and the PRESERFLO™ MicroShunt (MicroShunt). Methods Retrospective comparative case series of primary open‐angle glaucoma (POAG) patients with at least 6 months of
Lotte M.J. Scheres, Stefani Kujovic‐Aleksov, Wishal D. Ramdas, Ronald M.P.C. de Crom, Lianne C.G. Roelofs, Tos T.J.M. Berendschot, Carroll A.B. Webers, Henny J.M. Beckers   +7 more
wiley   +1 more source

XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications during a Long‐Term Follow‐Up

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
This study aimed to analyze the surgical and refractive outcomes of XEN glaucoma implant (Allergan, an Abbvie company, Irvine, CA, USA), a minimally invasive surgical device for the treatment of operated uncontrolled glaucoma. Eyes that received XEN Gel Stent placement from December 2014 to October 2019 were retrospectively investigated.
Katarzyna Lewczuk, Joanna Konopińska, Joanna Jabłońska, Jacek Rudowicz, Patrycja Laszewicz, Zofia Mariak, Marek Rękas, Giacinto Triolo   +7 more
wiley   +1 more source

Long‐Term Clinically Significant Posterior Capsular Opacification Development Pattern in Eyes Implanted with an Aspheric Monofocal Intraocular Lens with a Square Optic Edge

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Purpose. To analyse the posterior capsular opacification (PCO) development pattern in the long term in eyes implanted with a monofocal intraocular lens (IOL) with a square edge all around the optic. Methods. Longitudinal retrospective study is data analyzed from a total of 7059 eyes from 4764 patients (mean age: 75.8 years) undergoing cataract surgery ...
Javier Placeres Dabán, Juan Carlos Elvira, César Azrak, Lucía Rial, David P. Piñero, José I. Belda, Alessandro Meduri   +6 more
wiley   +1 more source